George Hucks

Statistics

Publications

Citations

404

H-Index

Active since

2014

Affiliations

Children's Hospital of Philadelphia(Current)

University of Pennsylvania

University of North Carolina at Chapel Hill

University of Michigan

George Hucks is an author at Children's Hospital of Philadelphia specializing in cytotoxic t lymphocyte responses, immunotherapy, and cancer immunotherapy.

ORCID

Publications per year

2014–2024

Publications

Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia

Amanda M. Li, George Hucks, Amanda M. DiNofia et al. · Blood · 2018 · 155 citations

Life Sciences, Immunology, Oncology +14

The effect of pembrolizumab in combination with CD19-targeted chimeric antigen receptor (CAR) T cells in relapsed acute lymphoblastic leukemia (ALL).

Shannon L. Maude, George Hucks, Alix E. Seif et al. · Journal of Clinical Oncology · 2017 · 96 citations

Life Sciences, Immunology, Oncology +17

Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma

Timothy Voorhees, Beibo Zhao, Jorge D. Oldan et al. · Blood Advances · 2021 · 48 citations · Full text

Medicine, Immunology, Oncology +17

Copper is a potent inhibitor of both the canonical and non-canonical NFκB pathways

Niall S. Kenneth, George Hucks, Andrew J. Kocab et al. · Cell Cycle · 2014 · 27 citations

Life Sciences, Biochemistry, Cell Biology +11

Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study

Natalie S. Grover, George Hucks, Marcie Riches et al. · The Lancet Haematology · 2024 · 26 citations · Full text

Medicine, Hematology, Oncology +17

1–5 of 8